Company Registration No. 09704146 (England and Wales)
GHEI MEDICALS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 JULY 2025
PAGES FOR FILING WITH REGISTRAR
GHEI MEDICALS LIMITED
CONTENTS
Page
Company information
Balance sheet
1 - 2
Notes to the financial statements
3 - 6
GHEI MEDICALS LIMITED
BALANCE SHEET
AS AT
31 JULY 2025
31 July 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
2,606
4,288
Current assets
Debtors
4
172,138
198,727
Cash at bank and in hand
129,708
34,942
301,846
233,669
Creditors: amounts falling due within one year
5
(244,309)
(177,064)
Net current assets
57,537
56,605
Net assets
60,143
60,893
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
60,043
60,793
Total equity
60,143
60,893

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

GHEI MEDICALS LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 JULY 2025
31 July 2025
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 20 May 2026 and are signed on its behalf by:
Dr. A Ghei
Director
Company registration number 09704146 (England and Wales)
GHEI MEDICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025
- 3 -
1
Accounting policies
Company information

Ghei Medicals Limited is a private company limited by shares incorporated in England and Wales. The registered office is Lynton House, 7-12 Tavistock Square, London, WC1H 9BQ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recover ed.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
25% straight line
Motor vehicles
25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

GHEI MEDICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
1
Accounting policies
(Continued)
- 4 -
1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors and loans from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

GHEI MEDICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
1
Accounting policies
(Continued)
- 5 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.10
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
4
4
GHEI MEDICALS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
- 6 -
3
Tangible fixed assets
Computers
Motor vehicles
Total
£
£
£
Cost
At 1 August 2024
26,188
92,678
118,866
Additions
229
-
0
229
At 31 July 2025
26,417
92,678
119,095
Depreciation and impairment
At 1 August 2024
21,900
92,678
114,578
Depreciation charged in the year
1,911
-
0
1,911
At 31 July 2025
23,811
92,678
116,489
Carrying amount
At 31 July 2025
2,606
-
0
2,606
At 31 July 2024
4,288
-
0
4,288
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
44,036
35,081
Other debtors
128,102
163,646
172,138
198,727
5
Creditors: amounts falling due within one year
2025
2024
£
£
Amounts owed to group undertakings
160,697
41,583
Corporation tax
50,662
71,629
Other creditors
32,950
63,852
244,309
177,064
2025-07-31 2024-08-01 false false false 20 May 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Dr. Aditi Ghei Mr. Maneesh Ghei 09704146 2024-08-01 2025-07-31 09704146 2025-07-31 09704146 2024-07-31 09704146 core:ComputerEquipment 2025-07-31 09704146 core:MotorVehicles 2025-07-31 09704146 core:ComputerEquipment 2024-07-31 09704146 core:MotorVehicles 2024-07-31 09704146 core:CurrentFinancialInstruments core:WithinOneYear 2025-07-31 09704146 core:CurrentFinancialInstruments core:WithinOneYear 2024-07-31 09704146 core:CurrentFinancialInstruments 2025-07-31 09704146 core:CurrentFinancialInstruments 2024-07-31 09704146 core:ShareCapital 2025-07-31 09704146 core:ShareCapital 2024-07-31 09704146 core:RetainedEarningsAccumulatedLosses 2025-07-31 09704146 core:RetainedEarningsAccumulatedLosses 2024-07-31 09704146 bus:Director1 2024-08-01 2025-07-31 09704146 core:ComputerEquipment 2024-08-01 2025-07-31 09704146 core:MotorVehicles 2024-08-01 2025-07-31 09704146 2023-08-01 2024-07-31 09704146 core:ComputerEquipment 2024-07-31 09704146 core:MotorVehicles 2024-07-31 09704146 2024-07-31 09704146 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 09704146 bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 09704146 bus:FRS102 2024-08-01 2025-07-31 09704146 bus:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 09704146 bus:Director2 2024-08-01 2025-07-31 09704146 bus:FullAccounts 2024-08-01 2025-07-31 xbrli:pure xbrli:shares iso4217:GBP